![]() ![]() The clinician–patient relationship remains at the core of medicine and health care. Finally, we briefly discuss the current and imagined utility of investigational methods including wearables and genetics in the diagnostic process and, through collaboration, the possibility of a new future in movement disorders and health care. We highlight contemporary clinical issues such as the ethics of diagnosing prodromal movement disorders and the appropriate application of genetic testing in clinical care. We further discuss current gaps, approaches to address them in the clinic, and attempt to foresee what the near future might bring. We discuss the use of investigational modalities such as neuroimaging in parkinsonism. We present diagnostic approaches to movement disorders, including but not limited to ataxia, chorea, tremor, and functional neurological disorders. Throughout this issue, we bring together a wonderful collection of movement disorder experts to discuss diagnostic challenges in various movement disorders. ![]() In addition, recent developments in imaging methods, neurophysiology, and genetics offer the chance for the clinician to incorporate the latest advances in biomedical research. Clinical diagnosis in movement disorders can inform the development of validated scales and personalized symptomatic therapies. It can lead to symptomatic treatment, prognostication, and better informed counseling. Accurate diagnosis, when delivered the correct way, can be therapeutic in its own right. The field of movement disorders, like others in medicine, is ripe with silos, gaps, and overlap between disorders. It is therefore important that our skills in diagnosis not only be celebrated and passed on from one generation to the next, but also constantly revisited and perfected. it is critical that diagnostic skills be correctly taught, discussed, and shared to provide care to patients perhaps seeing us in clinic on the worst day of their lives. With an aging population and projected increase in neurological disorders, and fewer than 5 neurologists per 100,000 people in the United States and even fewer elsewhere, The clinical diagnostician is as pertinent in the field of movement disorders as any, where clinical diagnosis is regarded as the gold standard to appropriate clinical care. A stellar example would be in stroke care, where such an approach led to eventual use of thrombolysis to minimize disability in the mid-90s and eventually, incorporation of endovascular treatments to reverse deficit in the last few years. Instead, clinicians incorporated available modalities into their repertoire and enabled major treatment advances. Answers to localization and presence of structural abnormalities including ischemic stroke and hemorrhage could be answered by direct visualization of the brain, thereby rendering the clinician's input ancillary, at best. In recent history, the demise of the clinical neurologist was first predicted in the early 1970s with the advent of the computed tomography scan. Buy Article Permissions and Reprints Abhimanyu Mahajan, MD, MHS Ludy C. ![]()
0 Comments
Leave a Reply. |